Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Sitagliptin, a dipeptidyl peptidase-4 inhibitor, was selected as an active-comparator placebo proxy because it was recommended in clinical guidelines as a second-line glucose-lowering therapy, had a similar high cost to the study drugs, showed no effect on cardiovascular outcomes in a large randomized controlled trial and has been validated as a placebo proxy in prior claims-based research 20,41
If more than five days have passed, skip the missed dose and resume your regular dosing schedule
Our dedicated team is focused on creating customized treatment plans that cater to your specific health needs
Appetite starts reducing
Maximum microdose ceiling: 0.25 mg weekly (which is the standard lowest therapeutic dose for weight loss, so anything at or below this is considered a microdose) Duration: Minimum 12 weeks before assessing overall efficacy
US$ 22.03
US$ 24.85
US$ 26.83
US$ 28.83
US$ 29.77
US$ 22.52
